The Discernable Interviews

Creator of COVAX-19: Professor Nikolai Petrovsky on Protein-Based vs mRNA Vaccines, Influenza and Mandates

54 Minutes

Professor Nikolai Petrovsky is the Director of Endocrinology at Flinders Medical Centre with a conjoint position as Professor of Medicine at Flinders University. He is Vice-President and Secretary-General of the International Immunomics Society.

Nikolai is the founder of Vaxine, a company funded by the US National Institutes of Health to develop novel vaccine technologies. in 2009 Vaxine won the Amp Innovation Award at the Telstra Business Awards and Australia’s Coolest Company award from Australian Anthill Magazine.

During his career Nikolai has developed vaccines against influenza, hepatitis b, sting allergy, malaria, Japanese Encephalitis, rabies and HIV, and has authored over 90 papers and academic chapters.

Nikolai’s company Vaxine which developed COVAX-19: 

1:47 SPIKOGEN receives a provisional determination from Australia’s Therapeutic Goods Administration (TGA)
3:25 How does SPIKOGEN compare to NovaVax?
6:22 SPIKOGEN approved in New Zealand
14:17 The safety of protein based vaccines
15:10 Adverse events with protein vaccines
17:22 The scientific data on SPIKOGEN
23:30 The historic crowdfunding of a vaccine
25:54 What are ‘breakthrough infections’?
30:09 Protein vaccines can be as fast as mRNA therapies
33:26 How to make spike proteins for different variants – genomic sequences
36:43 Injecting ready made spike proteins vs injecting mRNA
39:39 The different types of spike proteins
40:59 Why are mRNA vaccines causing thrombosis, myocarditis, pericarditis etc?
45:34 How does natural immunity compare to vaccinal immunity?
52:08 Omicron variant is not necessarily ‘less severe’ – we don’t know yet
54:17 Why viral attenuation is a myth
59:54 Nikolai Petrovsky vs Geert Vanden Bossche – antibody dependent enhancement
1:03:27 Population wide vaccination vs vulnerable vaccination
1:07:47 Should we vaccinate young children with SPIKOGEN?
1:09:56 The problem with comparing Covid-19 to influenza
1:16:46 SPIKOGEN is NOT a life-long prescription
1:22:30 How doctors used to weigh up risk vs benefit
1:25:46 COVAX is NOT COVAX-19…this is the difference
1:26:57 The professor took his own vaccine but it wasn’t good enough for government
1:29:53 The financial deal between Vaxine and Discernable to promote SPIKOGEN
1:30:18 EOI for SPIKOGEN clinical trials